BIOPHEN™ DTI — kromogeenne anti-IIa dabigatraani/bivalirudiini jaoks
Töötlemine...

BIOPHEN™ DTI — kromogeenne anti-IIa dabigatraani/bivalirudiini jaoks

Code: A220202-CAN
Manufacturer’s Part Number: 220202
Toote maht: 2 × 2,5 ml
Clearance: CE / HCL

Price: $436.00

Kogus

Toote kirjeldus

Chromogenic anti-IIa method for quantitative determination of direct thrombin inhibitors (DTIs) — specifically Dabigatran (Pradaxa®) and Bivalirudin — in citrated human plasma. Manual or automated method. CE-IVD.

  • Chromogenic approach complementary to clotting-based HEMOCLOT™ Thrombin Inhibitors
  • Validated for Dabigatran and Bivalirudin with dedicated calibrators

Toote omadused

  • Analüüsi kogukestus: ≤ 10 min
  • Detection Threshold:
      High Range (Hirudin): 0.30 µg/mL
      Low Range (Hirudin): 0.15 µg/mL
      Standard Range (Dabigatran): 14.6 ng/mL
      Low Range (Dabigatran): 6.3 ng/mL
  • Dynamic Range:
      High Range (Hirudin): 0 to 5 µg/mL
      Low Range (Hirudin): 0 to 2 µg/mL
      Standard Range (Dabigatran): 0 to 500 ng/mL
      Low Range (Dabigatran): 0 to 120 ng/mL
  • Intra-Assay CV: < 5%
  • Analüüsidevaheline korduvus (CV): < 5%
  • Testide arv (käsitsi meetod): 2 × 10 testi

Toote komponendid

  • R1: 2 x 2.5 mL Thrombin chromogenic substrate, lyophilized.
  • R2: 2 x 2.5 mL human Thrombin, lyophilized.
  • R3: 2 x 25 mL of Tris-BSA Buffer, ready to use.

Toote kasutusvaldkonnad

For the measurement of direct thrombin inhibitors in research applications.

Palun pange tähele: IVD-tooteid ei müüda USAs. Teave toote kättesaadavuse kohta USAs KLÕPSAKE SIIN